Marvel Biosciences Corp's market cap is currently C$6.72M. The company's EPS TTM is C$-0.063; its P/E ratio is ―; Marvel Biosciences Corp is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -887.52K	C$ -1.38M	C$ -613.10K	C$ -265.20K	C$ 0.00
Operating Income	C$ -2.32M	C$ -2.54M	C$ 806.33K	C$ -954.20K	C$ -100.05K
EBITDA	C$ -2.25M	C$ -2.51M	C$ -1.25M	C$ -1.02M	C$ -100.05K
Net Income	C$ -2.29M	C$ -2.55M	C$ -3.04M	C$ -955.66K	C$ -98.04K
Balance Sheet
Cash & Short-Term Investments	C$ 556.62K	C$ 593.21K	C$ 2.39M	C$ 224.81K	C$ 415.23K
Total Assets	C$ 672.39K	C$ 913.54K	C$ 2.47M	C$ 295.99K	C$ 417.24K
Total Debt	C$ 1.00M	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ 443.38K	C$ -593.21K	C$ -2.39M	C$ -224.81K	C$ -6.23K
Total Liabilities	C$ 2.39M	C$ 718.00K	C$ 112.48K	C$ 177.18K	C$ 3.08K
Stockholders' Equity	C$ -1.72M	C$ 195.54K	C$ 2.36M	C$ 118.80K	C$ 414.16K
Cash Flow
Free Cash Flow	C$ -1.33M	C$ -2.19M	C$ -1.37M	C$ -538.53K	C$ -41.80K
Operating Cash Flow	C$ -1.33M	C$ -2.19M	C$ -1.37M	C$ -538.53K	C$ -41.80K
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 381.57K	C$ 0.00	C$ -409.00K
Financing Cash Flow	C$ 1.30M	C$ 394.00K	C$ 3.16M	C$ 763.17K	C$ 457.03K

Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

Income Statement >

Marvel Biosciences Corp Debt to Assets

Balance Sheet >

Marvel Biosciences Corp Cash Flow

Cash Flow >

Marvel Biosciences Corp Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing